Torrent Pharmaceuticals has reported results for second quarter ended September 30, 2016.
The company has reported 75.26% fall in its net profit at Rs 169 crore for the quarter under review as compared to Rs 683 crore for the same quarter in the previous year. Total income of the company decreased by 32.99% at Rs 1117 crore for the quarter under review as compared Rs 1667 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 59.33% fall in its net profit after taxes, minority interest and share of profit of associates of Rs 207 crore for the quarter ended September 30, 2016 as compared to Rs 509 crore for the same quarter in the previous year. The total income of the company decreased by 16.55% at Rs 1472 crore for quarter under review as compared to Rs 1764 crore for the quarter ended September 30, 2015.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1508.40 |
Dr. Reddys Lab | 6332.85 |
Cipla | 1424.40 |
Zydus Lifesciences | 992.00 |
Lupin | 1663.00 |
View more.. |